BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2500
+0.0420 (20.19%)
May 26, 2026, 11:16 AM EDT - Market open
BioRestorative Therapies Stock Forecast
BRTX's stock price has decreased by -84.34% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 analysts polled by S&P Global, BioRestorative Therapies stock has a consensus rating of "Buy" and an average price target of $8.00. The average 1-year stock price forecast is 3,100.00% higher than the current stock price, while the lowest is $1.00 (+300.00%) and the highest is $15 (+5,900.00%).
Price Target: $8.00 (+3,100.00%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 9, 2026.
Analyst Ratings
The average analyst rating for BioRestorative Therapies stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Aug '25 | Nov '25 | Feb '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $1 | Buy | Maintains | $1 | +300.00% | Apr 9, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $18 → $15 | Buy | Maintains | $18 → $15 | +5,900.00% | Apr 2, 2026 |
Financial Forecast
Revenue This Year
1.43M
from 359.70K
Increased by 298.39%
Revenue Next Year
2.36M
from 1.43M
Increased by 64.62%
EPS This Year
-0.50
from -1.58
EPS Next Year
-0.41
from -0.50
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.6M | 3.3M | ||||||
| Avg | 1.4M | 2.4M | ||||||
| Low | 303,800 | 1.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 629.8% | 129.0% | ||||||
| Avg | 298.4% | 64.6% | ||||||
| Low | -15.5% | 2.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -0.35 | -0.30 | ||||
| Avg | -0.50 | -0.41 | ||||
| Low | -0.65 | -0.51 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.